The PurpleLab® Resource Center
Featured Resources
Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…
Creating a holistic direct to consumer (DTC) and healthcare provider (HCP) marketing strategy from scratch is a demanding task, especially if you don’t have the clinical expertise to precisely identify the consumers or providers you should be targeting. We’re here to give you 5 simple steps to creating a holistic DTC and HCP targeting strategy…
Life Sciences
Real-World Patient Examination of CAR-T Patient Characteristics and Treatment-Related Outcomes
Characterize the real-world CAR-T patient population by describing demographic and social drivers of health (SDOH) attributes at the time of therapy initiation.
Life Sciences
The U.S. generic drug supply is at a critical crossroad. With over 60% of generics made abroad, we face a fragile supply chain. This whitepaper analyzes how immediate tariffs to boost domestic manufacturing risk raising patient costs and disrupting access, and outlines the strategic, phased approach needed to secure our drug supply for the long term.
Life Sciences
Real-World Patient Characteristics and Outcomes Associated with Antibody-Drug Conjugate Therapy
This study was run to characterize patient demographics, cancer indications, treatment patterns, and survival outcomes in a large cohort of patients receiving ADC therapy.
Get In Touch
Questions? Ready for a demo or free trial of our healthcare analytics platform, HealthNexus™?
Contact us to get started.









